prazosin has been researched along with Mood Disorders in 2 studies
Prazosin: A selective adrenergic alpha-1 antagonist used in the treatment of HEART FAILURE; HYPERTENSION; PHEOCHROMOCYTOMA; RAYNAUD DISEASE; PROSTATIC HYPERTROPHY; and URINARY RETENTION.
prazosin : A member of the class of piperazines that is piperazine substituted by a furan-2-ylcarbonyl group and a 4-amino-6,7-dimethoxyquinazolin-2-yl group at positions 1 and 4 respectively.
Mood Disorders: Those disorders that have a disturbance in mood as their predominant feature.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
DeWeerdt, S | 1 |
Oluwabusi, OO | 1 |
Sedky, K | 1 |
Bennett, DS | 1 |
2 other studies available for prazosin and Mood Disorders
Article | Year |
---|---|
Mood disorders: the dark night.
Topics: Affect; Amygdala; Bipolar Disorder; Circadian Rhythm; Depression; Dreams; Electroencephalography; Gy | 2013 |
Prazosin treatment of nightmares and sleep disturbances associated with posttraumatic stress disorder: two adolescent cases.
Topics: Adolescent; Adrenergic alpha-Antagonists; Child; Child Abuse, Sexual; Dreams; Female; Humans; Learni | 2012 |